Pseudohypoparathyroidism historical perspective: Difference between revisions
Jump to navigation
Jump to search
Mazia Fatima (talk | contribs) |
Mazia Fatima (talk | contribs) |
||
| Line 4: | Line 4: | ||
=Overview= | =Overview= | ||
In 1942, Fuller albright, an American endocrinologist, first discovered pseudohypoparathyroidim and associated clinical features of Albright hereditary osteodystrophy. | In 1942, Fuller albright, an American endocrinologist, first discovered pseudohypoparathyroidim and associated clinical features of [[Albright's hereditary osteodystrophy|Albright hereditary osteodystrophy.]] | ||
==Historical Perspective== | ==Historical Perspective== | ||
Revision as of 19:09, 28 September 2017
|
Pseudohypoparathyroidism Microchapters |
|
Differentiating Pseudohypoparathyroidism from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Pseudohypoparathyroidism historical perspective On the Web |
|
American Roentgen Ray Society Images of Pseudohypoparathyroidism historical perspective |
|
Risk calculators and risk factors for Pseudohypoparathyroidism historical perspective |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mazia Fatima, MBBS [2]
Overview
In 1942, Fuller albright, an American endocrinologist, first discovered pseudohypoparathyroidim and associated clinical features of Albright hereditary osteodystrophy.
Historical Perspective
- In 1942, Fuller albright, an American endocrinologist, first discovered pseudohypoparathyroidim. Pseudohypoparathyoroidism is the first hormone resistance syndrome to be discovered.[1]
- In the same year, Albright hereditary osteodystrophy was clinically described together with pseudohypoparathyroidism. [2]